Price of HIV Prevention Drug Truvada

The House Oversight and Reform Committee convened a hearing to examine the high pricing of the HIV prevention drug Truvada. Daniel O’Day,… read more

The House Oversight and Reform Committee convened a hearing to examine the high pricing of the HIV prevention drug Truvada. Daniel O’Day, the CEO of Gilead, the company that makes the drug, testified on the pricing scheme and why the price for the pill is higher in the U.S. than in other countries. He said two of the reasons are because these countries have different health care systems than the U.S., and the other is because the drug is considered a generic abroad. Others who testified included physicians and HIV/AIDS advocates. close

Report Video Issue

People in this video

More People

Hosting Organization

More information about

Price of HIV Prevention Drug Truvada

2,378 Views
Program ID:
460810-1
Category:
House Committee
Format:
House Committee
Location:
2154, Rayburn House Office Building, Washington, District of Columbia, United States
First Aired:
May 16, 2019 | 10:01am EDT | C-SPAN.org
Last Aired:
May 21, 2019 | 2:24am EDT | C-SPAN 1

Airing Details

  • May 16, 2019 | 10:01am EDT | C-SPAN.org
  • May 19, 2019 | 3:37pm EDT | C-SPAN 1
  • May 20, 2019 | 8:59pm EDT | C-SPAN 1
  • May 21, 2019 | 2:24am EDT | C-SPAN 1
Purchase a Download

Price of HIV Prevention Drug Truvada

  • MP4 video - Low
    Price:
    Free
  • MP4 video - Standard
    Price:
    $6.99
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video

View all clips from this video